Transgene is a fully integrated biopharmaceutical company that designs and develops cutting-edge immunotherapeutic products to treat cancers and chronic infectious diseases. Our expertise covers all stages of product development, from research to the manufacture of clinical batches, and the conducting of clinical trials.

Four products are currently in clinical development :
TG4010, JX594/TG6006, TG4040 and TG4001 in phase II trials (summary of products in clinical development).

Transgene has concluded strategic agreements with two major pharmaceutical companies... » READ MORE